Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071032 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,016
- Enrollment target
NCT00071032: Completed Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
NCT00071032 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 2,016 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (161% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071032, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,016 participants
- Enrollment target
Study Summary
The purpose of this study is to compare liberal red blood cell transfusion therapy with restrictive red blood cell transfusion therapy in surgical patients with cardiovascular disease or risk factors.
Primary Outcome
ascertained via telephone follow-up
Interventions
- BIOLOGICAL Liberal (10 g/dL) Transfusion Strategy
- BIOLOGICAL Restrictive (Symptomatic) Transfusion Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,016 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-05 |
| Phase | Phase 3 |
What the finished NCT00071032 record still lists
NCT00071032 is an interventional study that assigns participants to a tested intervention. Its 2,016 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (161% higher).
The record links to 0 conditions, and to 2 interventions - of which Liberal (10 g/dL) Transfusion Strategy is the first listed.
NCT00071032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00071032 about?
NCT00071032 is a clinical study titled "Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease". The purpose of this study is to compare liberal red blood cell transfusion therapy with restrictive red blood cell transfusion therapy in surgical patients with cardiovascular disease or risk factors.
What is the current status of trial NCT00071032?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,016 participants. The study started on 2003-07. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00071032?
The interventions under investigation include: Liberal (10 g/dL) Transfusion Strategy (BIOLOGICAL), Restrictive (Symptomatic) Transfusion Strategy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00071032?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00071032's enrollment target sits among peer trials
2,016 100th of 2000 higher than 1,901 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia